What Happened?
San Diego, CA-based BioIntervene Appointed Gary Bennett as Chief Executive Officer
About the Company
BioIntervene, Inc. is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic inflammatory and neurodegenerative disorders. The Company was founded in 2014 based on insights from research at Saint Louis University and the National Institutes of Health (NIH). BioIntervene`s founding team has pioneered the understanding of adenosine A3 receptor biology, with a focus on developing first-in-class, selective adenosine A3 receptor agonists. California, United States Read more at CB Insights: https://www.cbinsights.com/company/BioIntervene
About the Person
Gary Bennett is Chief Executive Officer at BioIntervene. Previously, Gary held various senior HR leadership roles in the industry.
Info Source
News
Short Profile